IL17A and laryngotracheoesophageal cleft: The inflammatory IL-17, TNF, and toll-like receptor pathways are responsible for the modulation of not only the protumorigenic inflammation but also the proliferation, invasion, metastasis, migration, immune microenvironment, and treatment sensitivity of LC cells and tumors [128–134].